HOME › DRUGS › ELAFIBRANOR
ACTIVE SUBSTANCE / INN

ELAFIBRANOR

Brand name(s): Iqirvo, IQIRVO
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA218860
Liver Cirrhosis, Biliary
ACTIVE SUBSTANCE
Elafibranor
REGULATORS
FDA · EMA
SPONSORS / MAH
IPSEN, Ipsen Pharma
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
IQIRVONDA218860IPSENPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
IqirvoIpsen PharmaAuthorised19/09/2024Liver Cirrhosis, Biliary

FULL INTELLIGENCE ON ELAFIBRANOR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →